M.D., Assoc. Prof. Pathology & Laboratory Medicine and Pediatrics (Genetics), University of Vermont Health
Biography
Bob Wildin is the clinical and laboratory geneticist leading Vermonts healthcare-integrated Genomic Population Health testing program. The test sequences more than 400 genes in adults with any health status and has identified personal genetic health risks in up to one third of unselected adults and recessive carrier status in more than 85%. Dr. Wildin also attends on the Clinical Genetics service, interprets clinical somatic tumor NGS testing, teaches genetics across the medical education spectrum, and serves on an FDA Data Safety Monitoring Committee for a gene therapy trial. Dr. Wildin has practiced and done human genetics research in multiple US locations as well as in Paris, France. Dr. Wildin is passionate about closing the gaps. Before coming to Vermont, Dr. Wildin served as Chief of the Genomic Healthcare Branch at the National Human Genome Research Institute at NIH, where he promoted the integration of advances in genomic science into mainstream medical practice.
Session Abstract – PMWC 2023 Silicon Valley
Track 3 - January 27 9.00 A.M.-4.15 P.M.
Track Chairs:
Sharon Terry, Genetic Alliance & Alice Rathjen
- PMWC 2023 Award Ceremony:
Pioneer Honoree: David Bentley, Ilumina
- Learnings and Advancements of Population Studies (PANEL)
Chair: Sharon Terry, Genetic Alliance
- David Bentley, Illumina
- Slavé Petrovski, AstraZeneca
- Andrea Ganna, FinnGen
- Robert Wildin, University of Vermont Health
- Alexander Charney, Mount Sinai - Precision Medicine in Understudied Populations
- Ryan Taft, Illumina
- Aimé LUMAKA, WALGEMED - Building Future Precision Care in Qatar
Chair: Khalid Fakhro, Sidra Medicine
- Ziyad M. Hijazi, Sidra Medicine
- Edison T. Liu, The Jackson Labs
- Challenges and Opportunities for National Precision Medicine Initiatives (PANEL)
Chair: Alessandro Riccombeni, Microsoft UK
- Catalina Lopez-Correa, Genome Canada
- Khalid Fakhro, Sidra Medicine
- Framework to Improve the Translation of Genomics into the Clinic (PANEL)
Chair: Kathleen Barnes, Tempus Labs
- Carlos Bustamante, Galatea Bio
- Ora Gordon, Providence
- Abasi Ene-Obong, 54gene - Identifying Relationships Between Disparate Data Sets to Monitor and Control Pathogen Outbreak (PANEL)
Chair: Charles Chiu, UCSF
- Amy Kirby, CDC
- Smruthi Karthikeyan, Caltech - Increasing Diversity in Population Studies
- Manual Rivas - Global Biobank Engine, Stanford Rivas Lab
- The Missing Diversity in Human Epigenomic Studies
- Charles E. Breeze, National Cancer Institute
- The Transition from Genomics to Phenomics in Precision Population Health
- Lee Hood, Phenome Health
